CPC technology class · C07

C07H - Sugars

Sugars; derivatives thereof; nucleosides; nucleotides; nucleic acids. 6,464 US utility patents granted 2015–2025, with the leading assignees and year-by-year grant trajectory.

Compiled by PlainPatent · May 15, 2026

6,464
US patents granted: #6/8
in C07: 3.7%
C07 class share: -16%
5-yr velocity

The verdict

According to USPTO PatentsView, Sugars ranks #223 of 670 CPC technology areas - 6,464 US patents granted since 2015, with recorded grant volume down 16% over five years.

#223
of 670 CPC technology areas: 6,464
US patents granted, 2015–2025: The Regents of the…
leading assignee (97): -16%
grant velocity, last 5 yrs

How C07H's grant cadence moved

Between 2020–2024, C07H recorded 2,455 grants versus 2,915 in 2015–2019 (-16% equal-window velocity). Across complete years, output peaked in 2015 at 624 grants and bottomed in 2024 at 420 (+49% peak-over-trough). Lead assignee Ionis Pharmaceuticals, Inc. holds 1.3% of the class ; the top three share 3.2%.

Leaderboard read

C07H concentration, lead at 1.3%

Ionis Pharmaceuticals, Inc. leads this historical grant record at 1.3% of C07H - us corporation assignees hold 59% of class grants (2,413 of 4,081). Figures describe granted US utility patents in this CPC subclass, not current investment or legal strength.

Leader's share: 1.3%
Top three share: 3.2%
Lead over #2: 19

Where C07H sits inside C07

Among 8 subclasses in C07 (Organic Chemistry), C07H ranks #6 and holds 3.7% of the parent class's 176,064 recorded grants. Sibling chips below are the other subclasses in the same parent class, not the nationwide volume/lead-share peers further down.

C07K 58,046 C07D 54,914 C07C 32,521 C07F 14,249 C07B 8,058 C07J 1,454 C07G 358

Rising assignees active in C07H

Company-wide grant multiples (2022–2024 vs 2019–2021) among assignees with ≥5 patents in this subclass. Growth is company-wide; class patent counts are subclass-specific.

#1 Chr. Hansen HMO GmbH 17x 0 → 17 company-wide · 11 in C07H
#2 Hongene Biotech Corporation 15x 0 → 15 company-wide · 14 in C07H
#3 Singular Genomics Systems, Inc. 12x 7 → 81 company-wide · 16 in C07H
#4 Korro BIO, Inc. 5.00x 0 → 5 company-wide · 5 in C07H
#5 Avilar Therapeutics, Inc. 4.00x 0 → 4 company-wide · 7 in C07H

C07H grants by year, peak 2015 (624)

US utility-patent grants per year in C07H, 2015–2025 - recent five years are down 16% versus 2015–2019.

Ionis Pharmaceuticals

84
President and Fellows…

65
Life

57
Alnylam Pharmaceutical…

56
Gilead Sciences

53
The Trustees of…

50
Illumina Cambridge

50
Merck Sharp & Dohme

49
Pacific Biosciences…

48
Glycom A/S

44
Conagen

35
Purecircle Sdn Bhd

34

What this shows The Regents of the… is the most active filer in C07H, holding 97 of the 6,464 patents in this class. Concentration at the top signals how contestable this technology area is for new entrants.

View data table

Top patent holders in CPC subclass C07H
Rank	Company	Patents in C07H
#1	Ionis Pharmaceuticals, Inc.	84
#2	President and Fellows of Harvard College	65
#3	Life Technologies Corporation	57
#4	Alnylam Pharmaceuticals, Inc.	56
#5	Gilead Sciences, Inc.	53
#6	The Trustees of Columbia University in the City of New York	50
#7	Illumina Cambridge Limited	50
#8	Merck Sharp & Dohme LLC	49
#9	Pacific Biosciences OF California, Inc.	48
#10	Glycom A/S	44
#11	Conagen Inc.	35
#12	PureCircle Sdn Bhd	34
#13	Bristol-Myers Squibb Company	30
#14	The Trustees of the University of Pennsylvania	29
#15	Sirna Therapeutics, Inc.	29
#16	Translate BIO, Inc.	27
#17	Idenix Pharmaceuticals LLC	27
#18	Pfizer Inc.	26
#19	Emory University	26
#20	Enzo Life Sciences, Inc.	26

Footprint here vs. claim strategy

Each dot is a leading C07H assignee, placed by how many patents it holds in this class (horizontal) against its company-wide average claims per patent (vertical) - a read on whether the class is led by broad-but-shallow filers or focused deep-claim players.

Top 14 C07H assignees by class footprint. Bubble size = patents in C07H. Source: USPTO PatentsView (claim depth is company-wide across all classes).

Classes near C07H's 6,464-grant footprint

Nationwide nearest neighbors for C07H (#223 of 670 by volume ; lead share 1.5%) - not the C07 parent-class siblings above.

Nearest by grant volume

H02S 6,483 G01T 6,488 G08C 6,426 C11D 6,504

Nearest by lead-assignee share

A61L 1.5% G01K 1.5% C07K 1.5% C07D 1.5%

Questions about C07H

Which company holds the most patents in C07H?

The Regents of the University of California leads C07H with 97 patents (1.3% of the subclass). By PatentsView assignee type, us corporations account for 59% of class grants.

Which C07H assignees grew fastest recently?

Among assignees with ≥5 grants in C07H, Chr. Hansen HMO GmbH shows the highest company-wide grant multiple (17x: 0 grants in 2019–2021 → 17 in 2022–2024) while holding 11 patents in this subclass. Growth is company-wide, not class-only.

How does C07H compare inside parent class C07?

Inside C07 (Organic Chemistry), C07H ranks #6 of 8 subclasses by grant volume and holds 3.7% of the parent class total. The largest sibling is C07K (58,046 grants).

What to do with this data

C07H in context - here's where to go next.

Ionis Pharmaceuticals, Inc. leads C07H with 84 grants in this class. See full portfolio
C07H ranks #223 of 670 by grant volume among all tracked CPC technology areas. See the ranking
Inside parent class C07, the largest sibling subclass is C07K with 58,046 grants. Explore C07K

Figures reflect USPTO PatentsView grant data through 2026-05-15; pending applications not yet granted are not counted.

Methodology - C07H figures are USPTO PatentsView granted-utility totals for this subclass (6,464 grants in the tracked window).

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.